Sotrovimab and the Omicron Variant

Preliminary laboratory tests have indicated that Sotrovimab performs best against the Omicron variant. This may be due to the fact that Sotrovimab was designed to target a part of the spike protein that did not mutate between previous coronavirus strains and the Omicron variant.

Read More »

The Omicron Variant

The WHO announced a new variant of concern last Friday. The Omicron variant has around 50 mutations from previous strains of the coronavirus, including over 30 mutations on the spike protein.

Read More »